OPO Encyclopedia

Azathioprine Use Linked to Increased Squamous Cell Carcinoma Risk in Organ Transplant Recipients

A study finds that azathioprine, a common immunosuppressive drug used post-transplant, is linked to increased squamous cell carcinoma risk in organ transplant recipients. While this primarily affects transplant centers and recipient care, it underscores the downstream consequences of organ procurement decisions and the importance of optimizing donor-recipient matching.